New Hampshire HB 1566: relative to the New Hampshire prescription drug affordability board.

Status: Interim Study Report: Not Recommended for Future Legislation (Vote 14-0) (as of 2022-10-26)

State: New Hampshire · Session: 2022 · Bill: HB 1566

Sponsors: James Michael Murphy, Gary Merchant, Joyce Weston, Sharon M Carson, Tom Sherman, William M. Marsh

View New Hampshire HB 1566 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.